We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLAC
151
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$7.33M 0.03%
750,000
– –
WPCB
152
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$7.33M 0.03%
750,000
– –
GSEV
153
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
$7.33M 0.03%
750,000
– –
APGB
154
DELISTED
Apollo Strategic Growth Capital II
APGB
$7.33M 0.03%
750,000
– –
OPAL icon
155
OPAL Fuels
OPAL
$64.4M
$7.32M 0.03%
750,000
– –
TBCP
156
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$7.32M 0.03%
750,000
– –
RACB
157
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$7.32M 0.03%
750,000
– –
VAQC
158
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$7.31M 0.03%
750,000
– –
PANA
159
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$7.31M 0.03%
750,000
– –
LBPH
160
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$7.17M 0.03%
810,500
– –
NRGV icon
161
Energy Vault
NRGV
$691M
$7.03M 0.03%
710,451
+10,451
+1% +$102K
KVSA
162
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$6.91M 0.03%
700,000
– –
CORS
163
DELISTED
Corsair Partnering Corporation
CORS
$6.89M 0.03%
+700,000
New +$6.85M
STRE
164
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$6.8M 0.03%
700,000
– –
CCXI
165
DELISTED
ChemoCentryx, Inc.
CCXI
$6.6M 0.03%
+386,000
New +$6.01M
DAVE icon
166
Dave Inc
DAVE
$4.52B
$5.95M 0.03%
18,750
– –
GTPB
167
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$5.87M 0.03%
600,000
– –
RXRA
168
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
$5.83M 0.03%
600,000
– –
FSRX
169
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$5.83M 0.03%
600,000
– –
IPVI
170
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$5.82M 0.03%
600,000
– –
BWCAU
171
DELISTED
Blue Whale Acquisition Corp I Unit
BWCAU
$5.76M 0.03%
+575,000
New +$5.75M
NGCA
172
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
$5.46M 0.03%
+550,914
New +$5.45M
BCAB icon
173
BioAtla
BCAB
$5.3M
$5.3M 0.02%
3,600
-14,443
-80% -$28.1M
COGT icon
174
Cogent Biosciences
COGT
$6.37B
$5.05M 0.02%
600,000
– –
HMCO
175
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$5.03M 0.02%
508,900
– –
5 6
7
8 9

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.